Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label,... von Langdahl, Bente L, Libanati, Cesar, Crittenden, Daria B, Bolognese, Michael A, Brown, Jacques P, Daizadeh, Nadia S, Dokoupilova, Eva, Engelke, Klaus, Finkelstein, Joel S, Genant, Harry K, Goemaere, Stefan, Hyldstrup, Lars, Jodar-Gimeno, Esteban, Keaveny, Tony M, Kendler, David, Lakatos, Peter, Maddox, Judy, Malouf, Jorge, Massari, Fabio E, Molina, Jose Fernando, Ulla, Maria Rosa, Grauer, Andreas

Volltext

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years von Ferrari, S., Adachi, J. D., Lippuner, K., Zapalowski, C., Miller, P. D., Reginster, J.-Y., Törring, O., Kendler, D. L., Daizadeh, N. S., Wang, A., O’Malley, C. D., Wagman, R. B., Libanati, C., Lewiecki, E. M.

Volltext

FRI0289 Denosumab Treatment in Postmenopausal Women with Osteoporosis for Up to 9 Years: Results Through Year 6 of the Freedom Extension von Papapoulos, S., Roux, C., Bone, H.G., Dakin, P., Czerwiński, E., Frey, D., Kendler, D., Lewiecki, E.M., Malouf, J., Mellström, D., Reginster, J.Y., Resch, H., Daizadeh, N.S., Wang, A., Gavin, M., Wagman, R.B., Brandi, M.L.

Volltext

SAT0342 Treatment of postmenopausal women with osteoporosis for six years with denosumab: Three-year results from the freedom extension von Chapurlat, R., Papapoulos, S., Brown, J.P., Franchimont, N., Brandi, M.L., Czerwiński, E., Krieg, M.-A., Man, Z., Mellström, D., Radominski, S.C., Reginster, J.-Y., Resch, H., Román, J.A., Roux, C., Daizadeh, N.S., Geller, M.L., Smith, S., Wagman, R.B., Cummings, S.R., Bone, H.G.

Volltext

Denosumab treatment in postmenopausal women with osteoporosis for up to 9 years: results through year 6 of the freedom extension von Papapoulos, S, Roux, C, Bone, HG, Dakin, P, Czerwinski, E, Frey, D, Kendler, D, Lewiecki, EM, Malouf, J, Mellström, D, Reginster, Jean-Yves, Resch, H, Daizadeh, NS, Wang, A, Gavin, M, Wagman, RB, Brandi, ML

Volltext

Percentage of women achieving non-osteoporotic BMD T-scores at the lumbar spine (LS) and total hip (TH) during up to 8 years of Denosumab (Dmab) treatment von Ferrari, S, Libanati, C, Lin, CJF, Adami, S, Brown, JP, Cosman, F, Czerwinski, E, De Gregorio, LH, Malouf, J, Reginster, Jean-Yves, Daizadeh, NS, Wang, A, Wagman, RB, Lewiecki, EM, Cummings, S

Volltext

Percentage of women achieving non-osteoporotic BMD T-scores at the spine and hip over 8 years of denosumab treatment von Ferrari, S, Libanati, C, Lin, CJF, Adami, S, Brown, JP, Cosman, F, Czerwinski, E, de Gregorio, LH, Malouf, J, Reginster, Jean-Yves, Daizadeh, NS, Wang, A, Wagman, RB, Lewiecki, EM, Cummings, S

Volltext

Denosumab treatment of postmenopausal women with osteoporosis for 6 years : results from the first 3 years of the freedom extension von Papapoulos, S, Brown, JP, Chapurlat, R, Franchimont, N, Brandi, ML, Czerwinski, E, Krieg, MA, Man, Z, Mellström, D, Radominski, SC, Reginster, Jean-Yves, Resch, H, Roman, JA, Roux, C, Daizadeh, NS, Geller, ML, Smith, S, Wagman, RB, Cummings, SR, Bone, HG

Volltext

Treatment of postmenopausal women with osteoporosis for six years with denosumab : three-year results from the freedom extension von Chapurlat, R, Papapoulos, S, Brown, JP, Franchimont, N, Brandi, ML, Czerwinski, E, Krieg, MA, Man, Z, Mellstrom, D, Radominski, SC, Reginster, Jean-Yves, Resch, H, Roman, JA, Roux, C, Daizadeh, NS, Geller, ML, Smith, S, Wagman, RB, Cummings, SR, Bone, HG

Volltext